Cost of patient follow-up after potentially curative colorectal cancer treatment
- PMID: 7776499
Cost of patient follow-up after potentially curative colorectal cancer treatment
Abstract
Objective: To estimate the cost of follow-up among colorectal cancer patients treated with curative intent based on the broad spectrum of surveillance strategies suggested in the literature.
Design: Economic analysis of the costs associated with 11 separate surveillance strategies. Charge data were obtained from the Part B Medicare Annual Data file and the Hospital Outpatient Bill file.
Setting: Ambulatory care.
Main outcome measures: Medicare-allowed charges and an actual-charge proxy for 5 years of follow-up after treatment for colorectal cancer patients on a nationwide basis.
Results: Medicare-allowed charges varied widely for the 5 years of posttreatment follow-up from a low of $561 to a high of $16,492. When Medicare-allowed charges were converted to a proxy for actual charges using a conversion ratio of 1.62, the range was $910 to $26,717, a 28-fold difference in charges.
Conclusions: Charges vary extensively across follow-up strategies, with no indication that higher-cost strategies increase survival or quality of life.
Comment in
-
Follow-up testing for curatively treated cancer survivors. What to do?JAMA. 1995 Jun 21;273(23):1877-8. JAMA. 1995. PMID: 7776507 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
